Literature DB >> 8990729

Effects of Brazelton demonstrations on later parenting: a meta-analysis.

R Das Eiden1, A Reifman.   

Abstract

Meta-analysis of parenting interventions based on the Neonatal Behavioral Assessment Scale (NBAS) was conducted. Only published studies (n = 13) were included in this analysis, with one effect size entered for each study. The studies contained a total of 668 families, an average of about 51 per study. Effect sizes are reported in terms of the correlation coefficient (r) as well as the difference between experimental and control group means divided by the pooled standard deviation (Cohen's d). Analyses were conducted by weighting each study equally (unit weighting) and also by sample size. Similar average effect size were obtained for both weighting procedures (r's of about.2, d's of about.4), indicating that Brazelton-based interventions during the neonatal period have a small-moderate beneficial effect on the quality of later parenting. The probability of obtaining these findings by chance approached zero. The potential factors influencing these results are discussed, as well as directions for future research.

Mesh:

Year:  1996        PMID: 8990729     DOI: 10.1093/jpepsy/21.6.857

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  3 in total

1.  Project D.A.R.E. outcome effectiveness revisited.

Authors:  Steven L West; Keri K O'Neal
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

Review 2.  The Neonatal Behavioral Assessment Scale (NBAS) and Newborn Behavioral Observations (NBO) system for supporting caregivers and improving outcomes in caregivers and their infants.

Authors:  Jane Barlow; Nadeeja Ins Herath; Christine Bartram Torrance; Cathy Bennett; Yinghui Wei
Journal:  Cochrane Database Syst Rev       Date:  2018-03-14

3.  Mother-infant consultation during drug treatment: research and innovative clinical practice.

Authors:  C F Zachariah Boukydis; Barry M Lester
Journal:  Harm Reduct J       Date:  2008-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.